Alan F. Schatzberg

Clinical Focus

• Psychiatry

Administrative Appointments

• Chair, Stanford University School of Medicine - Psychiatry and Behavioral Sciences (1991 - present)

Professional Education

Postdoctoral Advisees

Amit Etkin, Keith Sudheimer

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Research Interests

Biological bases of depressive disorders;, glucocorticoid/dopamine interactions in delusional depression;, pharmacologic treatment of depressive disorders.

Clinical Trials

• Genetics of Symptomatology and Treatment Response in Psychotic Major Depression Recruiting

Publications

• FKBP5 polymorphisms and antidepressant response in geriatric depression. Sarginson JE, Lazzeroni LC, Ryan HS, Schatzberg AF, Murphy GM. Am J Med Genet B Neuropsychiatr Genet. 2009
• The silver lining of recent effectiveness trials. Schatzberg AF, World Psychiatry. 2009; 8 (1): 30-2
• Withdrawal symptoms over time among adolescents in a smoking cessation intervention: do symptoms vary by level of nicotine dependence? Bailey SR, Harrison CT, Jeffery CJ, Ammerman S, Bryson SW, Killen DT, Robinson TN, Schatzberg AF, Killen JD. Addict Behav. 2009; 34 (12): 1017-22
• Prefrontal plasticity and stress inoculation-induced resilience. Katz M, Liu C, Schaer M, Parker KJ, Ottet MC, Epps A, Buckmaster CL, Bammer R, Moseley ME, Schatzberg AF, Eliez S, Lyons DM. Dev Neurosci. 2009; 31 (4): 293-9
• Extended cognitive behavior therapy for cigarette smoking cessation. Killen JD, Fortmann SP, Schatzberg AF, Arredondo C, Murphy G, Hayward C, Celio M, Cromp D, Fong D, Pandurangi M. Addiction. 2008; 103 (8): 1381-90